Prostaglandin E2 stimulates S100A8 expression by activating protein kinase A and CCAAT/enhancer-binding-protein-beta in prostate cancer cells

International Journal of Biochemistry and Cell Biology

Volumn 44, Issue 11, 2012, Pages 1919-1928

  Miao, Lin ^a   Grebhardt, Sina ^b   Shi, Jiandang ^a   Peipe, Isabelle ^b   Zhang, Ju ^a   Mayer, Doris ^b  

^a NANKAI UNIVERSITY   (China)

^b GERMAN CANCER RESEARCH CENTER   (Germany)

Author keywords

Cyclic AMP; Prostaglandin; Prostanoid receptor signaling; Protein kinase A pathway; S100A8 A9

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; CALGRANULIN A; CALGRANULIN B; CCAAT ENHANCER BINDING PROTEIN BETA; CYCLIC AMP DEPENDENT PROTEIN KINASE; MESSENGER RNA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; SMALL INTERFERING RNA;

ARTICLE; BINDING SITE; CANCER CELL; CHROMATIN IMMUNOPRECIPITATION; CONCENTRATION RESPONSE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PROMOTER REGION; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

BASE SEQUENCE; BINDING SITES; CALGRANULIN A; CALGRANULIN B; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER;

EID: 84864516357     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2012.06.015     Document Type: Article

References (64)

1. S. Akira, H. Isshiki, T. Sugita, O. Tanabe, S. Kinoshita, and Y. Nishio A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family EMBO Journal 9 1990 1897 1906
2. A.F. Badawi The role of prostaglandin synthesis in prostate cancer BJU International 85 2000 451 462
3. M. Bando, Y. Hiroshima, M. Kataoka, M.C. Herzberg, K.F. Ross, and Y. Shinohara Modulation of calprotectin in human keratinocytes by keratinocyte growth factor and interleukin-1alpha Immunology and Cell Biology 88 2010 328 333
4. N. Belmonte, B.W. Phillips, F. Massiera, P. Villageois, B. Wdziekonski, and P. Saint-Marc Activation of extracellular signal-regulated kinases and CREB/ATF-1 mediate the expression of CCAAT/enhancer binding proteins beta and -delta in preadipocytes Molecular Endocrinology 15 2001 2037 2049
5. K. Boniface, F.X. Bernard, M. Garcia, A.L. Gurney, J.C. Lecron, and F. Morel IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes Journal of Immunology 174 2005 3695 3702
6. R. Chinery, J.A. Brockman, D.T. Dransfield, and R.J. Coffey Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein beta. A critical role for protein kinase A-mediated phosphorylation of Ser299 Journal of Biological Chemistry 272 1997 30356 30361
7. T.X. Cui, G. Lin, C.R. LaPensee, A.A. Calinescu, M. Rathore, and C. Streeter C/EBPbeta mediates growth hormone-regulated expression of multiple target genes Molecular Endocrinology 25 2011 681 693
8. P.B. Daniel, W.H. Walker, and J.F. Habener Cyclic AMP signaling and gene regulation Annual Review of Nutrition 18 1998 353 383
9. S.P. Davies, H. Reddy, M. Caivano, and P. Cohen Specificity and mechanism of action of some commonly used protein kinase inhibitors Biochemical Journal 351 2000 95 105
10. N.J. de Souza, A.N. Dohadwalla, and J. Reden Forskolin: a labdane diterpenoid with antihypertensive, positive inotropic, platelet aggregation inhibitory, and adenylate cyclase activating properties Medicinal Research Reviews 3 1983 201 219
11. D. DiSepio, M. Malhotra, R.A. Chandraratna, and S. Nagpal Retinoic acid receptor-nuclear factor-interleukin 6 antagonism. A novel mechanism of retinoid-dependent inhibition of a keratinocyte hyperproliferative differentiation marker Journal of Biological Chemistry 272 1997 25555 25559
12. R. Donato S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles International Journal of Biochemistry and Cell Biology 33 2001 637 668
13. R.L. Eckert, A.M. Broome, M. Ruse, N. Robinson, D. Ryan, and K. Lee S100 proteins in the epidermis Journal of Investigative Dermatology 123 2004 23 33
14. J.M. Ehrchen, C. Sunderkotter, D. Foell, T. Vogl, and J. Roth The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer Journal of Leukocyte Biology 86 2009 557 566
15. J.E. Friedman Role of glucocorticoids in activation of hepatic PEPCK gene transcription during exercise American Journal of Physiology 266 1994 E560 E566
16. C.D. Funk Prostaglandins and leukotrienes: advances in eicosanoid biology Science 294 2001 1871 1875
17. C. Gebhardt, J. Nemeth, P. Angel, and J. Hess S100A8 and S100A9 in inflammation and cancer Biochemical Pharmacology 72 2006 1622 1631
18. S. Ghavami, S. Chitayat, M. Hashemi, M. Eshraghi, W.J. Chazin, and A.J. Halayko S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis European Journal of Pharmacology 625 2009 73 83
19. S. Ghavami, I. Rashedi, B.M. Dattilo, M. Eshraghi, W.J. Chazin, and M. Hashemi S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway Journal of Leukocyte Biology 83 2008 1484 1492
20. A. Greenhough, H.J. Smartt, A.E. Moore, H.R. Roberts, A.C. Williams, and C. Paraskeva The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment Carcinogenesis 30 2009 377 386
21. S. Gupta, M. Srivastava, N. Ahmad, D.G. Bostwick, and H. Mukhtar Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma Prostate 42 2000 73 78
22. L.A. Habel, W. Zhao, and J.L. Stanford Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US Cancer Causes and Control 13 2002 427 434
23. A.N. Hata, and R.M. Breyer Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation Pharmacology & Therapeutics 103 2004 147 166
24. M.O. Henke, A. Renner, B.K. Rubin, J.I. Gyves, E. Lorenz, and J.S. Koo Up-regulation of S100A8 and S100A9 protein in bronchial epithelial cells by lipopolysaccharide Experimental Lung Research 32 2006 331 347
25. A. Hermani, B. De Servi, S. Medunjanin, P.A. Tessier, and D. Mayer S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells Experimental Cell Research 312 2006 184 197
26. A. Hermani, J. Hess, B. De Servi, S. Medunjanin, R. Grobholz, and L. Trojan Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer Clinical Cancer Research 11 2005 5146 5152
27. P.A. Hessian, J. Edgeworth, and N. Hogg MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes Journal of Leukocyte Biology 53 1993 197 204
28. S. Hiratsuka, A. Watanabe, H. Aburatani, and Y. Maru Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis Nature Cell Biology 8 2006 1369 1375
29. S. Hiratsuka, A. Watanabe, Y. Sakurai, S. Akashi-Takamura, S. Ishibashi, and K. Miyake S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase Nature Cell Biology 10 2008 1349 1355
30. J.A. Hobbs, R. May, K. Tanousis, E. McNeill, M. Mathies, and C. Gebhardt Myeloid cell function in MRP-14 (S100A9) null mice Molecular and Cellular Biology 23 2003 2564 2576
31. M. Ichikawa, R. Williams, L. Wang, T. Vogl, and G. Srikrishna S100A8/A9 Activate key genes and pathways in colon tumor progression Molecular Cancer Research 9 2011 133 148
32. E.J. Jacobs, C. Rodriguez, A.M. Mondul, C.J. Connell, S.J. Henley, and E.E. Calle A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence Journal of the National Cancer Institute 97 2005 975 980
33. H. Kawai, Y. Minamiya, and N. Takahashi Prognostic impact of S100A9 overexpression in non-small cell lung cancer Tumour Biology 32 2011 641 646
34. M.H. Kim, and J. Field Translationally regulated C/EBPβ isoform expression upregulates metastatic genes in hormone-independent prostate cancer cells Prostate 68 2008 1362 1371
35. M. Kiriyama, F. Ushikubi, T. Kobayashi, M. Hirata, Y. Sugimoto, and S. Narumiya Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells British Journal of Pharmacology 122 1997 217 224
36. M. Klempt, H. Melkonyan, H.A. Hofmann, and C. Sorg Identification of epithelial and myeloid-specific DNA elements regulating MRP14 gene transcription Journal of Cellular Biochemistry 73 1999 49 55
37. A. Kumar, A. Steinkasserer, and S. Berchtold Interleukin-10 influences the expression of MRP8 and MRP14 in human dendritic cells International Archives of Allergy and Immunology 132 2003 40 47
38. R. Kuruto-Niwa, M. Nakamura, K. Takeishi, and R. Nozawa Transcriptional regulation by C/EBP alpha and -beta in the expression of the gene for the MRP14 myeloid calcium binding protein Cell Structure and Function 23 1998 109 118
39. C. Li, F. Zhang, M. Lin, and J. Liu Induction of S100A9 gene expression by cytokine oncostatin M in breast cancer cells through the STAT3 signaling cascade Breast Cancer Research and Treatment 87 2004 123 134
40. A.C. Manolakis, A.N. Kapsoritakis, E.K. Tiaka, and S.P. Potamianos Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease Digestive Diseases and Sciences 56 2011 1601 1611
41. F.H. Marshall, K. Patel, K. Lundstrom, J. Camacho, S.M. Foord, and M.G. Lee Characterization of [3H]-prostaglandin E2 binding to prostaglandin EP4 receptors expressed with Semliki Forest virus British Journal of Pharmacology 121 1997 1673 1678
42. S. Medunjanin, A. Hermani, B. De Servi, J. Grisouard, G. Rincke, and D. Mayer Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor alpha and is involved in the regulation of receptor activity Journal of Biological Chemistry 280 2005 33006 33014
43. R. Metz, and E. Ziff cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to trans-locate to the nucleus and induce c-fos transcription Genes and Development 5 1991 1754 1766
44. W. Nacken, and C. Kerkhoff The hetero-oligomeric complex of the S100A8/S100A9 protein is extremely protease resistant FEBS Letters 581 2007 3510 5127
45. J. Nemeth, P. Angel, and J. Hess Dual role of S100A8 and S100A9 in inflammation-associated cancer Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 8 2009 329 336
46. J. Nemeth, I. Stein, D. Haag, A. Riehl, T. Longerich, and E. Horwitz S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis Hepatology 50 2009 1251 1262
47. M. Niehof, M.P. Manns, and C. Trautwein CREB controls LAP/C/EBP beta transcription Molecular and Cellular Biology 17 1997 3600 3613
48. S. Osada, H. Yamamoto, T. Nishihara, and M. Imagawa DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family Journal of Biological Chemistry 271 1996 3891 3896
49. D.P. Ramji, and P. Foka CCAAT/enhancer-binding proteins: structure, function and regulation Biochemical Journal 365 2002 561 575
50. A. Rammes, J. Roth, M. Goebeler, M. Klempt, M. Hartmann, and C. Sorg Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway Journal of Biological Chemistry 272 1997 9496 9502
51. D.K. Rhee, S.H. Park, and Y.K. Jang Molecular signatures associated with transformation and progression to breast cancer in the isogenic MCF10 model Genomics 92 2008 419 428
52. A. Saha, Y.C. Lee, Z. Zhang, G. Chandra, S.B. Su, and A.B. Mukherjee Lack of an endogenous anti-inflammatory protein in mice enhances colonization of B16F10 melanoma cells in the lungs Journal of Biological Chemistry 285 2010 10822 10831
53. M. Schmitt, and M. Pawlita High-throughput detection and multiplex identification of cell contaminations Nucleic Acids Research 37 2009 e119
54. E.M. Smyth, T. Grosser, M. Wang, Y. Yu, and G.A. FitzGerald Prostanoids in health and disease Journal of Lipid Research 50 Suppl. 2009 S423 S428
55. H.J. Tae, S. Zhang, and K.H. Kim cAMP activation of CAAT enhancer-binding protein-beta gene expression and promoter I of acetyl-CoA carboxylase Journal of Biological Chemistry 270 1995 21487 21494
56. O. Turovskaya, D. Foell, P. Sinha, T. Vogl, R. Newlin, and J. Nayak RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis Carcinogenesis 29 2008 2035 2043
57. T. Vogl, S. Ludwig, M. Goebeler, A. Strey, I.S. Thorey, and R. Reichelt MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes Blood 104 2004 4260 4268
58. T. Vogl, K. Tenbrock, S. Ludwig, N. Leukert, C. Ehrhardt, and M.A. van Zoelen Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock Nature Medicine 13 2007 1042 1049
59. D. Wang, and R.N. Dubois Eicosanoids and cancer Nature Reviews. Cancer 10 2010 181 193
60. X. Wang, and R.D. Klein Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway Molecular Carcinogenesis 46 2007 912 923
61. D.F. Woodward, D.J. Pepperl, T.H. Burkey, and J.W. Regan 6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist Biochemical Pharmacology 50 1995 1731 1733
62. K. Xu, and Geczy C.L. IFN-gamma and TNF regulate macrophage expression of the chemotactic S100 protein S100A8 Journal of Immunology 64 2000 916 4923
63. K. Xu, T. Yen, and C.L. Geczy Il-10 up-regulates macrophage expression of the S100 protein S100A8 Journal of Immunology 166 2001 6358 6366
64. D.B. Zimmer, E.H. Cornwall, A. Landar, and W. Song The S100 protein family: history, function, and expression Brain Research Bulletin 37 1995 417 429